Join to View Full Profile
908 Jefferson StSeattle, WA 98104
Phone+1 206-616-8948
Dr. Rosenbloom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rosenbloom is a board-certified neurologist at the UW Medicine Memory and Brain Wellness Center where he directs the clinical trials running at the UW Alzheimer’s Disease Research Center (ADRC) in Seattle, WA. He previously served for 13 years as director of the HealthPartners Center for Memory and Aging in St. Paul, MN where he led clinical research in cognitive screening for dementia, intranasal therapeutics, and non-invasive neurostimulation for neurodegenerative diseases.
Education & Training
Columbia University Vagelos College of Physicians and SurgeonsClass of 2004
Certifications & Licensure
CA State Medical License 2008 - Present
WA State Medical License 2022 - 2025
MN State Medical License 2010 - 2023
WI State Medical License 2015 - 2023
MA State Medical License 2009 - 2010
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Intracerebral hemorrhage following mild ARIA-H in an APOE ε2 carrier receiving lecanemab.Sung Ji, Michael Rosenbloom
Alzheimer's Research & Therapy. 2024-12-19 - 3 citationsA Framework for the Administration of Anti-amyloid Monoclonal Antibody Treatments in Early-Stage Alzheimer's Disease.Michael H Rosenbloom, Tricia O'Donohue, Domi Zhou-Clark, Deepashni Mala, Andrew Frazier
CNS Drugs. 2024-07-01 - Open label pilot of personalized, neuroimaging-guided theta burst stimulation in early-stage Alzheimer's disease.Bhavani Kashyap, Leah R Hanson, Sally K Gustafson, Terry Barclay, Clarissa M Howe
Frontiers in Neuroscience. 2024-01-01
Press Mentions
UW Medicine Administers New Alzheimer’s Drug for the First TimeDecember 4th, 2023
External Links
- Leqembi Webinarhttps://depts.washington.edu/mbwc/news/article/leqembi-webinar
- What the FDA Approval of Lecanemab Means for Patients and Families: A Q&A with MBWC Clinicianshttps://depts.washington.edu/mbwc/news/article/lecanemab
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
